We conducted a population-based birth cohort study of approximately 203,000 babies born in northeastern Italy (1989Italy ( -2012 to investigate perinatal variables, early infections leading to hospital admission, and antibiotic use in the first 12 months of life as possible risk factors for celiac disease (CD). Incident CD cases were identified from pathology reports, hospital discharge records, and exemptions from prescription charges for clinical tests. Multivariate Poisson regression models were fitted to estimate incidence rate ratios (IRRs). A total of 1,227 children had CD; CD was histopathologically confirmed in 866 (71%). Female sex, maternal age, and high maternal educational level were found to be significantly associated with CD. Gastrointestinal infections were strongly associated with a subsequent diagnosis of CD (IRR = 2.04, 95% confidence interval (CI): 1.30, 3.22). Antibiotic use was significantly associated with CD onset (IRR = 1.24, 95% CI: 1.07, 1.43), with a dose-response relationship for number of courses (P-trend < 0.01). Cephalosporin use strongly increased the risk of CD (IRR = 1.42, 95% CI: 1.18, 1.73). Use of antibiotics (supported by the dose-response relationship) and gastrointestinal infections in the first year of life may facilitate the early onset of CD by altering intestinal microflora and the gut mucosal barrier. Perinatal factors, including cesarean section, had little influence on the risk of childhood CD.
Celiac disease (CD) is a chronic autoimmune small-intestine enteropathy triggered by gluten (1) . CD affects approximately 1% of the European population, and it is commonly diagnosed during childhood (2) . Small-intestine biopsy with villous atrophy (Marsh stage 3) is the gold-standard method of CD diagnosis (3, 4) .
The etiology of CD is not fully understood, though it is clear that CD is strongly associated with human leukocyte antigen genes (4) . Other relevant risk factors include breastfeeding alone or in combination with time of gluten introduction (5, 6) . While differences in genetics and gluten consumption might partly explain differences in CD rates, environmental factors are also believed to play a role in the disease's development (7) . Investigators have previously studied the influence of several perinatal and sociodemographic risk factors for CD, with contradictory results (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) .
Both the composition of the intestinal flora and the localization of bacteria in the epithelium have been associated with mucosal inflammation (20, 21) . The gut microbiota retain an important role in regulating intestinal immune response and mucosal barrier function (22) . The postnatal period seems to be a particularly important phase for enteric host-microbe homeostasis, and intestinal infection and antibiotic use in the first months of life may disrupt the normal microbial colonization of the gut, contributing to CD onset (10, 22, 23) .
In a recent case-control study, Mårild et al. (18) showed an association between antibiotic use and subsequent CD diagnosed at any age, hypothesizing a role for intestinal microbial imbalance to explain this finding. Some epidemiologic studies have suggested that neonatal and early childhood infections increase the risk of CD later in life (7, 9, 10) , though other studies have had different findings (12, 15) . The lack of a proper cohort study design and reliance on data reported by parents or on birth charts to identify episodes of infection make most such studies scarcely reliable.
Using linked health administrative data from the epidemiologic record system of the Friuli-Venezia Giulia region of Italy, we conducted a population-based birth cohort study to investigate perinatal variables, early infections, and antibiotic use as possible risk factors for CD.
METHODS

Setting and study population
Italy has a tax-based national health service which provides universal coverage, as in most European countries. Health care is delivered free or upon copayment to all Italian and European Union citizens residing in the country, regardless of income. The Italian health service is organized at a regional level, by means of a network of providers that might be publicly or privately owned, although the right of patients to obtain health care outside the region is granted with similar financial conditions.
The study was conducted in the Friuli-Venezia Giulia region of northeastern Italy. The region has a population of approximately 1.2 million and 10,000 births per year (Italian National Institute of Statistics, unpublished data (http://www.demo.istat.it/)).
Data collection
The Friuli-Venezia Giulia region is covered by an automated centralized record system developed in the 1980s with the goal of automatically collecting and pooling data on health care funded by the national health service using a unique anonymous regional identification code. The following health data were used in this study: 1) pathology reports from all of the pathology departments in the region, coded using the Systematized Nomenclature of Medicine (available from 1989 onward); 2) hospital discharge records collected during inpatient care episodes occurring within or outside of the region, with up to 6 diagnostic codes from the International Classification of Diseases, Ninth Revision (ICD-9) (available from 1990 onward); 3) exemptions from health-care copayment, which are recorded in a national coding system (available from 2002 onward); 4) drug prescription records coded under the Anatomical-Therapeutic-Chemical (ATC) Classification System (available from 1995 onward); 5) mortality records (available from 1989 onward); and 6) regional medical birth register (Certificato di Assistenza al Parto) data (available from 1989 onward), including information on the parents, details of the pregnancy, labor, and delivery, and the newborn at birth.
Derivation of study variables
Incident cases of CD were identified using 1) pathology reports of villous atrophy (Systematized Nomenclature of Medicine codes D6218, D6318, M58, M58005, M58006, and M58007), 2) hospital discharge records with ICD-9 code 5790 in all diagnoses, and 3) records of all persons exempted from health-care copayment with code I0060 in the national coding system. Concerning the latter data, all patients with CD can obtain clinical tests and gluten-free food free of charge from the national health service, provided that they have a CD diagnosis with histopathological confirmation.
Among the medical birth register data, we considered the following variables as possible risk factors: sex; season of birth (October-April or May-September); number of older siblings (0, 1, or ≥2); parity (1 or ≥2); birth weight (≥2,500 g or <2,500 g); gestational age (≤28, 29-35, or ≥36 weeks); Apgar scores at 1 and 5 minutes (≥7 or <7); child's birth presentation (vertex, breech, or other); maternal age (<25, 25-29, 30-34, 35-39, or ≥40 years); type of delivery (spontaneous, planned cesarean, unplanned cesarean, or other; data were available from 2002 onwards); and mother's formal education (up to sixth grade, up to eighth grade, up to 13th grade, or university).
Early infection was defined as hospitalization for any type of infection (ICD-9 codes 130-139) or for gastrointestinal infection (ICD-9 codes 001-009) before 12 months of age, identified using hospital discharge records. Data on antibiotic use (ATC Classification System code J01*) before 12 months of age were identified from the Drug Prescription Register. Antibiotics were grouped into the subgroups most often prescribed: penicillins (ATC code J01C*), cephalosporins (ATC code J01D*), and macrolides (ATC code J01F*). Other types of antibiotics, such as quinolones, were not analyzed separately because of the small number of infants treated with these medications. Since the antibacterial spectrum varies for different types of cephalosporins, we examined prescriptions for first-and second-generation drugs ( particularly active against Grampositive bacteria) separately from those for third-and fourthgeneration products (more active against Gram-negative bacteria).
Data analyses
All of the children born in the Friuli-Venezia Giulia region during the period 1989-2012 were enrolled in the study. Abortions, stillbirths, and early neonatal deaths (deaths occurring within 30 days of birth) were excluded, as were babies with less than a year of follow-up, to ensure a proper temporal relationship between episodes of infection and CD diagnoses.
The time of CD onset was considered to be the earliest date identifiable in one of the 3 sources of information ( pathology records, hospital records, and exemptions from copayment). Follow-up started at 1 year of age (i.e., from January 1, 1990 , or later) and ended with the earliest of the following: the end of the study (December 31, 2012), death, transfer out of the area, or CD diagnosis. Children given a CD diagnosis within the first year of life were considered as being already sick at the beginning of follow-up and therefore were excluded from the analysis. The number of years of follow-up for each event was calculated as the difference between the date of CD onset and the date of loss to follow-up or December 31, 2012, as appropriate. This permitted a maximum follow-up period of 23 years (up to a maximum age of 24 years).
We fitted Poisson models to estimate incidence rate ratios and 95% confidence intervals for each of the possible risk factors for CD. Results from all models were adjusted for year of birth and sex. Analyses on hospitalization for infections and antibiotic prescriptions were restricted to babies born after 1990 and 1995, respectively.
In a sensitivity analysis conducted to obtain a more specific definition of CD, we restricted our analyses to cases confirmed by a pathological diagnosis of villous atrophy, and we also adjusted for maternal education. We additionally stratified our analyses by age at the time of CD diagnosis (1-3 years, >3-6 years, or >6 years) because early-onset CD may have different risk factors than late-onset CD. To assess potential causality, we examined the dose-response association between antibiotic use and subsequent CD diagnosis considering the number of courses of antibiotics as both a categorical variable (1-2, 3-4, or ≥5 courses) and a continuous variable. We also restricted the analysis to antibiotic exposure before 6 months of age (instead of 1 year) to establish whether this exposure really preceded CD.
RESULTS
We enrolled 214,845 newborns from the Friuli-Venezia Giulia region during the period 1989-2012. After exclusion of abortions, stillbirths, and early neonatal deaths, 213,635 newborns were left in our birth cohort. After removing children with less than a year of follow-up, the final cohort consisted of 203,557 subjects ( Figure 1 ).
With a total of 2,243,922 person-years of follow-up, 1,227 children with CD were identified. Of the 1,227 CD cases, 866 (71%) were histopathologically confirmed ( Figure 1 ); 291 cases (23.7%) were diagnosed before the age of 3 years, 310 (25.3%) were diagnosed between the ages of 3 and 6 years, and 626 (51%) were diagnosed at over 6 years of age (mean age = 7.55 (standard deviation, 5.20) years; median age, 6.37 years). The median durations of follow-up were 10.75 years (range, 0.08-23) for children without CD and 5.33 years (range, 0.08-22.42) for children with CD. Table 1 shows potential demographic, perinatal, and socioeconomic risk factors for CD. Females were at higher risk of developing CD than were males (incidence rate ratio (IRR) = 1.69, 95% confidence interval (CI): 1.51, 1.90). Babies born weighing less than 2,500 g were at greater risk (IRR = 1.23, 95% CI: 0.98, 1.53), and so were babies born very preterm, at ≤28 weeks (IRR = 1.95, 95% CI: 0.87, 4.35), but the findings did not reach statistical significance. None of the other factors relating to childbirth (season of birth, number of older siblings, parity, Apgar score, child's birth presentation, or mode of delivery) were found to be associated with CD. We found a significant association between CD and maternal age (babies with 30-to 39-year-old mothers were at greater risk), with no clear temporal pattern. There was a significantly increased risk of CD for babies born to mothers with a university degree (IRR = 1.24, 95% CI: 1.10, 1.40). The results remained much the same when the analyses were restricted to histopathologically confirmed CD cases (Table 1) .
Infections requiring hospitalization in the first year of life were significantly associated with subsequent development of CD (IRR = 1.39, 95% CI: 1.01, 1.91) ( Table 2) . Hospital admissions for intestinal infections were associated with a 2-fold increased risk of developing CD (IRR = 2.04, 95% CI: 1.30, 3.22). The risks were slightly lower when histopathologically confirmed cases were analyzed.
Children who had received treatment with at least 1 antibiotic during their first year of life were at higher risk of developing CD (IRR = 1.24, 95% CI: 1.07, 1.43) ( Table 3) . This risk increased when the analysis was restricted to the histopathologically confirmed CD cases (IRR = 1.31, 95% CI: 1.10, 1.56). The risk of developing CD increased significantly with increasing number of courses of antibiotic treatment (P-trend < 0.01). Among the 1,721,541 antibiotic prescriptions dispensed in this birth cohort's first year of life, penicillin was the most often prescribed antibiotic (53%), followed by macrolides (22%) and cephalosporin (21%). The use of penicillin was associated with subsequent onset of CD only when the analysis was restricted to biopsy-confirmed cases of villous atrophy (IRR = 1.24, 95% CI: 1.03, 1.49). Cephalosporin use was strongly associated with CD onset (IRR = 1.42, 95% CI: 1.18, 1.73), and also when we restricted the analyses to histopathologically confirmed cases of CD (IRR = 1.51, 95% CI: 1.21, 1.89). The risk of subsequent CD was even slightly higher for the third-and fourth-generation drugs (first-and second-generation drugs: IRR = 1.39, 95% CI: 1.11, 1.76; third-and fourth-generation drugs: IRR = 1.49, 95% CI: 1.14, 1.95). Macrolide use revealed no association with the onset of CD (Table 3 ). The risk for use of any antibiotic in the first 6 months of life dropped slightly and was significant only for histopathologically confirmed cases of CD (IRR = 1.23, 95% CI: 1.00, 1.52), whereas cephalosporin use remained strongly associated with CD (for all diagnoses, IRR = 1.44, 95% CI: 1.07, 1.93) (data not shown). Table 4 shows results of the analysis stratified by age at CD diagnosis. Risks for hospital admission for intestinal infections and for total antibiotic and penicillin use were detected only among children diagnosed with CD at ages 1-3 years, whereas risks for cephalosporin did not differ appreciably by year of age at diagnosis, with the highest IRR being detected for diagnosis between 3 and 6 years of age (IRR = 1.57, 95% CI: 1.13, 2.16). Macrolide use was not associated with CD diagnosis at any age.
Adjustment for the mother's educational level revealed persistently significant IRRs for both number of episodes of infection and use of antibiotics (data not shown).
DISCUSSION
Perinatal risk factors appeared to play a limited role in the etiology of CD in our study. Associations were found for female sex and, to a lesser extent, for low birth weight and older maternal age. Other pregnancy-and birth-related variables (number of older siblings, parity, Apgar score, child's birth presentation, and mode of delivery) were not associated with CD. Elective cesarean section may alter the composition of the microbiota due to missed colonization by the vaginal flora (15), but previous findings are inconsistent (11, 13, 15) . In our study, information on the mode of delivery was available only from 2002 onwards; therefore, we cannot exclude the possibility that with greater statistical power and a longer follow-up period we would have detected such an association.
On the other hand, our analysis indicated that babies born to better educated mothers had a 30% higher risk of developing CD than babies born to mothers who had completed only their compulsory formal education. Few studies have evaluated the influence of socioeconomic status (SES) on the risk of CD, with some finding an association with high SES (10, 16, 19, 24) , others an association with low SES (7, 11, 14) , and still others reporting no differences (25) . One possible interpretation of our findings could be that high-SES families generally have a better health education and may therefore consult a doctor even for mild symptoms of CD, and may be more likely to undertake serological screening (19) . A second reason for our findings is that different SES levels produce different exposures. A low SES has been shown to protect against childhood autoimmune diseases (e.g., atopic diseases), possibly because of lower hygiene levels (26) . According to the "hygiene hypothesis," deficient early colonization with normal microbial flora due to better public health and living conditions ( particularly among high-SES groups) can increase susceptibility to allergy, autoimmune disease, and CD (19, 26) . The hygiene hypothesis (or, more accurately, the microflora hypothesis) can explain the association between SES and CD but also the role of infection as a risk factor for CD, since altered microbial colonization of the gut can disrupt the mucosal barrier and the local immune system (22) , predisposing a person to infections that in turn perpetuate the disruption of the microbiota.
Consistently with this hypothesis, some studies have shown that celiac patients' intestinal flora differ from those of healthy controls, with more proinflammatory bacterial species and fewer antiinflammatory ones (27) (28) (29) . Intestinal pathogens may also favor the development of gluten-induced autoimmunity, either by directly inducing local inflammation (30) or through a molecular mimicry mechanism (31). In our study, infections in the first year of life were significantly associated with a subsequent diagnosis of CD (IRR = 1.39, 95% CI: 1.01, 1.91). We found an even stronger association when we considered only exposure to intestinal infections (IRR = 2.04, 95% CI: 1.30, 3.22), and the association remained statistically significant when we restricted our analysis to histologically confirmed CD cases. Few epidemiologic studies have investigated the role of infections occurring at birth (9, 15) and during the early months of life (7, 10, 12) as a risk factor for CD, and they have had variable results. Neonatal infections were found to increase the risk of childhood CD in 1 register-based study (9) , whereas a later study was unable to confirm the association (15) . In 2 case-control studies, infections during the first months of life, as reported by parents, were more frequent in children with CD than in controls (7, 12) . When the analysis was restricted to gastroenteritis, however, the association was no longer reported (12) or it disappeared after adjustment for SES and breastfeeding (7) .
To the best of our knowledge, our study is the first to have used hospitalizations to identify infectious disease episodes Early Infections, Antibiotics, and Celiac Disease 79 instead of relying on parents' reports (7, 12) or birth charts (9, 15) . Unfortunately, we cannot exclude the possibility that our findings are partially explained by detection bias. In a post hoc analysis, the IRR for any hospital admission (excluding admissions at birth and those for infections) before 1 year of age was in fact 1.68 (95% CI: 1.44, 1.95). Although infections occurred during the first 12 months of life and CD was diagnosed after 1 year of age, hospitalizations can lead to detailed examinations that increase the chance of CD diagnosis.
We found that antibiotic use during the first year of life was significantly associated with a subsequent diagnosis of CD (IRR = 1.24, 95% CI: 1.07, 1.43), with a dose-response relationship (P-trend < 0.01). Although this finding might simply reflect the association between early infections and CD, we hypothesize that antimicrobial agents may also independently disrupt the gut's immunological balance by altering the local microbial ecosystem. Exposure to antibiotics in childhood has been associated with a greater susceptibility to immunological disorders such as inflammatory bowel disease (32) and asthma (33) . As far as we know, only 2 studies had previously investigated the association between antibiotic treatment and subsequent CD (7, 18) . In a post hoc analysis based on information reported by parents, Myléus et al. (7) found antibiotic treatments during the first 6 months of life to be unassociated with CD (odds ratio = 1.2, 95% CI: 0.87, 1.6). Conversely, Mårild et al. (18) , on the basis of record linkage with a drug prescription register, showed that having received at least 1 course of antibiotics at any time of life increased the risk of developing CD afterwards (odds ratio = 1.40, 95% CI: 1.27, 1.53), and the risk was higher the greater the number of courses. Notably, the latter study originally considered prescriptions for all age groups, while a subsequent post hoc analysis on prescriptions in the first 6 months of life was limited by the small sample size, so the hypothesis that early antibiotic use may influence the developing intestinal immune system was not specifically addressed.
Our results showed that cephalosporin use greatly increased the risk of CD, irrespective of whether we used a broader definition of CD (IRR = 1.42, 95% CI: 1.18, 1.73) or restricted the analysis to histologically confirmed cases (IRR = 1.51, 95% CI: 1.21, 1.89), whereas penicillin was associated only with histologically diagnosed cases Table continues 80 Canova et al. Abbreviations: CD, celiac disease; CI, confidence interval; ICD-9, International Classification of Diseases, Ninth Revision; IRR, incidence rate ratio; PR, pathology report.
a Analyses were restricted to children born after 1990 (hospital discharge records were available only from 1990 onward).
b Restricted to cases with a pathology report confirming CD. c Adjusted for sex and year of birth. d P < 0.05. (IRR = 1.24, 95% CI: 1.03, 1.49). No significant association emerged for macrolides. Antibiotics may have different effects on the intestinal microflora depending on their spectrum of activity and pharmacokinetic profile (23, 34) . Mårild et al. had previously examined different categories of antibiotics and had found a significant association for extendedspectrum penicillins, quinolones, macrolides, other types of antibiotics, metronidazole, and antiparasitic drugs (18), but they did not distinguish cephalosporins from other types of antibiotics. That study was conducted among persons with CD diagnosed at any age, and their exposures and biological responses to the various types of antibiotics may differ from those of newborn babies. Cephalosporins (especially those of the third and fourth generation) have a broad antibacterial spectrum and therefore might cause a deeper and more persistent dysregulation of the gut microbiota than other types of antibiotics (35) . A subanalysis of our data showed that the risk of subsequent CD increased significantly for both earlier and later cephalosporins, but it was slightly higher for the latter. When the analyses were stratified by age at diagnosis, we found that cephalosporin use increased the risk of CD's being diagnosed at any age, but more so beyond the age of 3 years, whereas the effect of penicillin was apparent only for early diagnoses (those made between 1 and 3 years of age). We speculate that cephalosporins might cause prolonged disruption of the gut microbiota and consequently increase a person's susceptibility to CD even years after their use. An alternative explanation is that cephalosporins may be preferred for children with a history of hypersensitivity reactions to penicillin, who may already have an individual predisposition to immunological disorders. Some epidemiologic studies have shown a higher risk of infection in celiac patients (36) (37) (38) , hypothesizing a role for hyposplenism and nutritional deficits. Thus, it may be that our results are partially due to reverse causation explained by more frequent infectious episodes in babies not yet diagnosed with CD. Early clinical signs of CD may be misdiagnosed as gastroenteritis, and the same logic may apply to antibiotic use, since it might be a marker of infection. However, in an effort to ensure a proper temporal relationship, we only examined infections occurring in the first year of life, and we estimated the risk of CD's being diagnosed from 1 year of age onwards. When our analysis was restricted to antibiotic prescriptions given in the first 6 months of life, we still detected a significant risk of subsequent CD. This makes us confident that the association between antibiotics and CD cannot be justified by detection bias or reverse causation, because gluten exposure generally begins 6 months after birth, and therefore babies under 6 months of age are unlikely to have undiagnosed CD.
The major strength of our study lies in the large, clearly defined population considered, with a total of 2,243,922 person-years of follow-up and more than 1,200 CD cases. CD was identified for the first time using a multisource definition linking hospital records, pathology records, and exemptions from copayment. Using this multisource definition, we were able to identify children who might have undergone biopsy outside of the Friuli-Venezia Giulia region. During the period from 2002 to 2012 (for which data from all 3 sources were available), 75% of CD children were identified by at least 2 of these data sources. In previous populationbased record-linkage studies, CD was identified in various ways-that is, from hospital records (9, 11, 14) , a central CD registry (7, 8) , or pathology reports (15, 16, 18) , which remains the gold standard (3). Restricting our analysis to children with a histopathological diagnosis of CD (866 out of 1,227 cases) influenced the risk estimates only marginally. Therefore, the chance of our including false-positive diagnoses in our analysis should have been low. We are quite confident that we retrieved all data on antibiotic use among these children. All medications prescribed in the Friuli-Venezia Giulia region are recorded and coded in the regional database, and pharmacies are reimbursed by the national health service on the basis of this recorded information. Antibiotics are dispensed and reimbursed only by prescription, and the accuracy of the ATC Classification System codes used to identify antibiotics is high. We are aware that misclassification of CD cases might have occurred using both definitions (with different proportions of false-positive and false-negative diagnoses). However, we believe that, at least concerning exposure to antibiotics, this would have been a nondifferential misclassification bias (i.e., exposed and nonexposed people are equally likely to be misclassified according to disease status), which tends to produce "false-negative" findings. Another important strength of this study lies in the fact that all exposures and outcomes were recorded separately and were only subsequently brought together by record linkage, so our findings were not affected by any interview or recall bias. Educational level has already been associated with gastrointestinal infections (39) and the use of antibiotics (18) , but the association between early infectious episodes and the use of antibiotics (any antibiotics or cephalosporins) did not change appreciably after adjustment for maternal education: Infections, antibiotic use, and family SES seemed to be independent risk factors for the onset of CD.
In conclusion, perinatal exposures seem to play a small role in the etiology of CD. Early gastrointestinal infections, use of antibiotics, and a high level of maternal education seem to be independent risk factors for the onset of childhood CD, possibly explained by altered microbial colonization of the gut. To our knowledge, this is the first study to have found a strong association between cephalosporin use in the first months of life and CD risk. As with any novel finding, this warrants further research because of the possible implications for disease prevention.
